Breast malignancy risk for ladies with atypical hyperplasia higher than thought previously Pfizer.

Breast malignancy risk for ladies with atypical hyperplasia higher than thought previously, study finds Females with atypical hyperplasia of the breasts have a higher risk of developing breast tumor than previously idea, a Mayo Clinic research has found. Results of the study appear in a particular report on breast cancer in the New England Journal of Medication. Atypical hyperplasia of the breast is a precancerous condition within about one-tenth of the over 1 million breast biopsies with benign results performed each year in the United States Pfizer click here . Viewed under a microscope, atypia contains breasts cells that are beginning to grow out of control and cluster into unusual patterns .